These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32446036)

  • 21. Antiviral drugs that target cellular proteins may play major roles in combating HIV resistance.
    Provencher VM; Coccaro E; Lacasse JJ; Schang LM
    Curr Pharm Des; 2004; 10(32):4081-101. PubMed ID: 15579090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments.
    Menéndez-Arias L
    Antiviral Res; 2013 Apr; 98(1):93-120. PubMed ID: 23403210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
    Mori M; Kovalenko L; Malancona S; Saladini F; De Forni D; Pires M; Humbert N; Real E; Botzanowski T; Cianférani S; Giannini A; Dasso Lang MC; Cugia G; Poddesu B; Lori F; Zazzi M; Harper S; Summa V; Mely Y; Botta M
    ACS Chem Biol; 2018 Jan; 13(1):253-266. PubMed ID: 29235845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.
    Hartman TL; Yang L; Helfrick AN; Hassink M; Shank NI; George Rosenker K; Scerba MT; Saha M; Hughes E; Wang AQ; Xu X; Gupta P; Buckheit RW; Appella DH
    Antiviral Res; 2016 Oct; 134():216-225. PubMed ID: 27568924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication.
    Maeda K; Das D; Kobayakawa T; Tamamura H; Takeuchi H
    Curr Top Med Chem; 2019; 19(18):1621-1649. PubMed ID: 31424371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes.
    Roche M; Borm K; Flynn JK; Lewin SR; Churchill MJ; Gorry PR
    Curr Top Med Chem; 2016; 16(10):1091-106. PubMed ID: 26324043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exportin-1-Dependent Nuclear Export of DEAD-box Helicase DDX3X is Central to its Role in Antiviral Immunity.
    Heaton SM; Atkinson SC; Sweeney MN; Yang SNY; Jans DA; Borg NA
    Cells; 2019 Sep; 8(10):. PubMed ID: 31575075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on HIV resistance and resistance testing.
    Sebastian J; Faruki H
    Med Res Rev; 2004 Jan; 24(1):115-25. PubMed ID: 14595674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
    De Luca A; Hamers RL; Schapiro JM
    J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.
    Yedavalli VS; Zhang N; Cai H; Zhang P; Starost MF; Hosmane RS; Jeang KT
    J Med Chem; 2008 Aug; 51(16):5043-51. PubMed ID: 18680273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of Novel HIV-1/2 Fusion Inhibitors with High Therapeutic Efficacy in Rhesus Monkey Models.
    Chong H; Xue J; Zhu Y; Cong Z; Chen T; Guo Y; Wei Q; Zhou Y; Qin C; He Y
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What clinicians need to know about antiviral drugs and viral resistance.
    Hodinka RL
    Infect Dis Clin North Am; 1997 Dec; 11(4):945-67. PubMed ID: 9421709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DEAD-box RNA helicase DDX3X inhibits DENV replication via regulating type one interferon pathway.
    Li G; Feng T; Pan W; Shi X; Dai J
    Biochem Biophys Res Commun; 2015 Jan; 456(1):327-32. PubMed ID: 25437271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-resistance to viral entry inhibitors.
    Menéndez-Arias L; Esté JA
    Curr Pharm Des; 2004; 10(15):1845-60. PubMed ID: 15180544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy.
    Balzarini J
    Biochem Pharmacol; 1999 Jul; 58(1):1-27. PubMed ID: 10403515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical Differences and Similarities between the DEAD-Box Helicase Orthologs DDX3X and Ded1p.
    Sharma D; Putnam AA; Jankowsky E
    J Mol Biol; 2017 Nov; 429(23):3730-3742. PubMed ID: 29037760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3.
    Maga G; Falchi F; Garbelli A; Belfiore A; Witvrouw M; Manetti F; Botta M
    J Med Chem; 2008 Nov; 51(21):6635-8. PubMed ID: 18834110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular strategies to design an escape-proof antiviral therapy.
    Berkhout B; Sanders RW
    Antiviral Res; 2011 Oct; 92(1):7-14. PubMed ID: 21513746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV inhibitors: problems and reality.
    Tözsér J
    Ann N Y Acad Sci; 2001 Nov; 946():145-59. PubMed ID: 11762983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.